Electromed Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Electromed stock.
View analyst ratings for Electromed or view top-rated stocks.

Wall Street analysts have given Electromed a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Electromed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Electromed is scheduled to release its next quarterly earnings announcement on Tuesday, May 11th 2021.
View our earnings forecast for Electromed.

Electromed, Inc. (NYSEAMERICAN:ELMD) released its earnings results on Monday, February, 8th. The medical equipment provider reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.09. The medical equipment provider earned $9.50 million during the quarter, compared to analysts' expectations of $8.25 million. Electromed had a trailing twelve-month return on equity of 12.39% and a net margin of 11.44%.
View Electromed's earnings history.

Electromed's stock was trading at $9.29 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ELMD stock has increased by 7.6% and is now trading at $10.00.
View which stocks have been most impacted by COVID-19.

2 brokerages have issued 1 year price targets for Electromed's shares. Their forecasts range from $15.00 to $21.00. On average, they anticipate Electromed's stock price to reach $18.00 in the next year. This suggests a possible upside of 80.0% from the stock's current price.
View analysts' price targets for Electromed or view top-rated stocks among Wall Street analysts.

Some companies that are related to Electromed include Edap Tms (EDAP), Second Sight Medical Products (EYES), BioSig Technologies (BSGM), FONAR (FONR), IRIDEX (IRIX), ENDRA Life Sciences (NDRA), Soleno Therapeutics (SLNO), electroCore (ECOR), Helius Medical Technologies (HSDT), Fc Global Realty (FCRE), Viveve Medical (VIVE), CHF Solutions (CHFS), ReShape Lifesciences (RSLS), Precision Optics (PEYE) and Vaso (VASO).
View all of ELMD's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include AbbVie (ABBV), TransEnterix (TRXC), AT&T (T), ACADIA Pharmaceuticals (ACAD), CRISPR Therapeutics (CRSP), Enphase Energy (ENPH), Inseego (INSG), Novavax (NVAX), NVIDIA (NVDA) and Pfizer (PFE).

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

Electromed's stock is owned by many different institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.54%) and Morgan Dempsey Capital Management LLC (0.08%).
View institutional ownership trends for Electromed.

ELMD stock was acquired by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, and Morgan Dempsey Capital Management LLC.
View insider buying and selling activity for Electromed or or view top insider-buying stocks.

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ELMD stock can currently be purchased for approximately $10.00.

Electromed has a market capitalization of $86.35 million and generates $32.47 million in revenue each year. The medical equipment provider earns $4.16 million in net income (profit) each year or $0.47 on an earnings per share basis.

Electromed employs 120 workers across the globe.

The official website for Electromed is smartvest.com.

Electromed is headquartered at 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States.

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299 or via email at [email protected]